Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
Recruiting now
Conditions studied: Chronic Hepatitis B
In brief
This study is a prospective, open-label, multicenter long-term follow-up study to evaluate the durability of virologic response in subjects with chronic hepatitis B previously treated with AHB-137 injection.
Key facts
- Study ID
- NCT07146100
- Run by
- Ausper Biopharma Co., Ltd.
- People needed
- 200
- Starts
- 2025-08-28
- Expected to finish
- 2030-01-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Capable of giving informed consent.
- Participants who have previously received at least one dose of AHB-137 and achieved the complete of partial response in the parent study without rescue medication and who maintained response until the End of Study (EoS) visit in their parent study.
You may not qualify if…
- Participants who have/or are currently participating in another interventional clinical study since completing their treatment with AHB-137.
- Suspected for cancer at screening or any condition required hospitalization during this study , or any condition which, in the opinion of the investigator or Medical Monitor, contraindicates their participation in this study.
Where it is running
- AusperBio Investigational Site — Chongqing, Chongqing Municipality, China (enrolling)
- AusperBio Investigational Site — Fuzhou, Fujian, China (enrolling)
- AusperBio Investigational Site — Guangzhou, Guangdong, China (enrolling)
- AusperBio Investigational Site — Guangzhou, Guangdong, China (enrolling)
- AusperBio Investigational Site — Changhou, Jiangsu, China (enrolling)
- AusperBio Investigational Site — Zhenjiang, Jiangsu, China (enrolling)
- AusperBio Investigational Site — Changchun, Jilin, China (enrolling)
- AusperBio Investigational Site — Hangzhou, Zhejiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.